Anemia, a condition characterized by a reduced number of red blood cells or hemoglobin, poses a significant diagnostic challenge due to its wide array of potential causes. This article aims to provide a comprehensive guide to the diagnostic approach to anemia for healthcare professionals.
The initial evaluation of anemia should include a thorough patient history and physical examination. Key aspects to consider are dietary habits, family history, medications, and potential symptoms of underlying conditions. Laboratory tests should include a complete blood count (CBC), reticulocyte count, and peripheral smear.
Anemia can be classified based on the mean corpuscular volume (MCV) into microcytic, normocytic, and macrocytic anemia. This classification helps narrow down the potential causes and guide further investigations.
Further investigations depend on the initial classification. Microcytic anemia may suggest iron deficiency or thalassemia, warranting iron studies or hemoglobin electrophoresis. Normocytic anemia may be due to chronic diseases, hemolysis, or marrow failure, necessitating tests such as reticulocyte count, haptoglobin, lactate dehydrogenase (LDH), and bone marrow examination. Macrocytic anemia may be caused by vitamin B12 or folate deficiency, myelodysplastic syndrome, or alcoholism, requiring tests like serum B12, folate levels, and bone marrow examination.
If the cause of anemia remains elusive after these investigations, referral to a hematologist may be warranted. This is particularly important in cases suggestive of bone marrow disorders or malignancies.
In conclusion, diagnosing anemia requires a systematic approach starting with a detailed patient history, physical examination, and initial laboratory tests. Classification based on MCV can guide further investigations. Referral to a specialist should be considered if the cause remains unclear after initial investigations.
1.
In Patients with Myeloma Who Postpone HSCT, Quadruplet Displays "Excellent Activity.".
2.
Characterizing metastatic disease during adaptive therapy by using dynamic biomarkers and mathematical modeling.
3.
Alarm Over Pharma-China Link; Taking Screening to the People; Agriculture and Cancer
4.
CAR T cells improve patients' quality of life: a study
5.
Preoperative Embolization Linked to Relapse-Free Survival in Meningioma
1.
The Digital Revolution in Oncology - How Software, AI, and Data are Reshaping Cancer Care by 2025
2.
Advances in Cancer Detection: From Genetic Risk to Molecular Biomarkers
3.
Bone Marrow Niche Remodeling in Hematologic Dysfunction
4.
Public Health Strategies for Expanding Early Support Systems in Blood Disorders
5.
Clinical Pharmacology of Megakaryocyte Maturation-Targeted Therapeutics
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
3.
Exploring the Hospitalization Burden in Refractory and Relapsed ALL
4.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I
5.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation